{"id":156172,"date":"2026-02-04T15:38:23","date_gmt":"2026-02-04T15:38:23","guid":{"rendered":"https:\/\/www.europesays.com\/se\/156172\/"},"modified":"2026-02-04T15:38:23","modified_gmt":"2026-02-04T15:38:23","slug":"svagt-q4-for-apotea-jag-ar-inte-nojd","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/se\/156172\/","title":{"rendered":"Svagt Q4 f\u00f6r Apotea: \u201dJag \u00e4r inte n\u00f6jd\u201d"},"content":{"rendered":"

Tappar marknadsandelar<\/p>\n

Under f\u00f6rra \u00e5rets sista kvartal v\u00e4xte den svenska apoteksmarknadens oms\u00e4ttning med 14% j\u00e4mf\u00f6rt med samma kvartal \u00e5ret f\u00f6re, visar\u00a0Svensk Handels<\/strong>\u00a0indikator.<\/p>\n

Samtidigt visar den f\u00e4rska kvartalsrapporten att Apoteas oms\u00e4ttning v\u00e4xte med bara 7%. Det \u00e4r sj\u00e4tte kvartalet i rad som Apotea v\u00e4xer l\u00e5ngsammare \u00e4n apoteksmarknaden.<\/p>\n

Men P\u00e4r Sv\u00e4rdson tror \u00e4nd\u00e5 inte att bolaget tappar marknadsandelar i fjol\u00e5rets sista kvartal.<\/p>\n

\u201dDet skulle f\u00f6rv\u00e5na mig, men det finns ju ingen statistik f\u00f6r det \u00e4n\u201d, s\u00e4ger P\u00e4r Sv\u00e4rdson.<\/p>\n

\u201dVi ligger antagligen ganska n\u00e4ra tillv\u00e4xten f\u00f6r marknaden.\u201d<\/p>\n

I det tredje kvartalet 2025 v\u00e4xte konkurrenten\u00a0Meds\u00a0<\/strong>22% medan Apoteas tillv\u00e4xt var 9%.<\/p>\n

\u201dJag tror att konkurrensen \u00e4r bra f\u00f6r oss. Ju h\u00e5rdare konkurrens vi har, ju starkare blir vi. F\u00f6r oss \u00e4r det absolut positivt att konkurrenterna k\u00e4mpar\u201d, s\u00e4ger VD:n.<\/p>\n

Vad \u00e4r era konkurrensf\u00f6rdelar?<\/strong><\/p>\n

\u201dVi ser till att vara b\u00e4ttre och vassare.\u201d<\/p>\n\n

Apotea i Mkr<\/p>\n

Q4-2025<\/p>\n

Q4-2024<\/p>\n

F\u00f6r\u00e4ndring<\/p>\n<\/tr>\n\n\n

Nettooms\u00e4ttning<\/p>\n<\/td>\n\n

1 854,3<\/p>\n<\/td>\n\n

1 732,9<\/p>\n<\/td>\n\n

7,0%<\/p>\n<\/td>\n<\/tr>\n\n\n

R\u00f6relseresultat<\/p>\n<\/td>\n\n

24,5<\/p>\n<\/td>\n\n

51,9<\/p>\n<\/td>\n\n

-52,8%<\/p>\n<\/td>\n<\/tr>\n\n\n

R\u00f6relsemarginal<\/p>\n<\/td>\n\n

1,3%<\/p>\n<\/td>\n\n

3,0%<\/p>\n<\/td>\n<\/tr>\n\n\n

Nettoresultat<\/p>\n<\/td>\n\n

14,2<\/p>\n<\/td>\n\n

48,8<\/p>\n<\/td>\n\n

-70,9%<\/p>\n<\/td>\n<\/tr>\n\n\n

Resultat per aktie, kronor<\/p>\n<\/td>\n\n

0,15<\/p>\n<\/td>\n\n

0,48<\/p>\n<\/td>\n\n

-68,8%<\/p>\n<\/td>\n<\/tr>\n\n\n

Kassafl\u00f6de fr\u00e5n l\u00f6pande verksamhet<\/p>\n<\/td>\n\n

-64,7<\/p>\n<\/td>\n\n

28,3<\/p>\n<\/td>\n<\/tr>\n\n\n

Ordinarie \u00e5rsutdelning per aktie, kronor<\/p>\n<\/td>\n\n

0,60<\/p>\n<\/td>\n\n<\/tr>\n","protected":false},"excerpt":{"rendered":"Tappar marknadsandelar Under f\u00f6rra \u00e5rets sista kvartal v\u00e4xte den svenska apoteksmarknadens oms\u00e4ttning med 14% j\u00e4mf\u00f6rt med samma kvartal…\n","protected":false},"author":2,"featured_media":73553,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[5],"tags":[6600,22,23,26,27,17,21,24,25,28,29,14669,15,16,18,34,31,33,32,30,19,20],"class_list":["post-156172","post","type-post","status-publish","format-standard","has-post-thumbnail","category-rubriker","tag-apotea","tag-breaking-news","tag-breakingnews","tag-featured-news","tag-featurednews","tag-headlines","tag-huvudnyheter","tag-latest-news","tag-latestnews","tag-main-news","tag-mainnews","tag-meds","tag-news","tag-nyheter","tag-rubriker","tag-se","tag-svenska","tag-sverige","tag-sweden","tag-swedish","tag-top-stories","tag-topstories"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@se\/116013111924615742","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts\/156172","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/comments?post=156172"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts\/156172\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/media\/73553"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/media?parent=156172"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/categories?post=156172"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/tags?post=156172"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}